vs

Side-by-side financial comparison of HARROW, INC. (HROW) and UNITIL CORP (UTL). Click either name above to swap in a different company.

UNITIL CORP is the larger business by last-quarter revenue ($161.5M vs $89.1M, roughly 1.8× HARROW, INC.). UNITIL CORP runs the higher net margin — 11.8% vs 7.4%, a 4.3% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 26.7%). HARROW, INC. produced more free cash flow last quarter ($8.1M vs $-36.3M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs -4.9%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

Unitil Corporation is an interstate electricity and natural gas utility company that provides services for New Hampshire, Massachusetts and Maine. Its earliest predecessor company, the Portland Gas Light Company, was founded in Maine in 1849. The current company was set up in 1984 and is based in New Hampshire. With a market cap of 686.51M, it provides electric services to about 102,400 customers and natural gas to over 75,900 customers. The service territory of Unitil includes business distr...

HROW vs UTL — Head-to-Head

Bigger by revenue
UTL
UTL
1.8× larger
UTL
$161.5M
$89.1M
HROW
Growing faster (revenue YoY)
HROW
HROW
+6.6% gap
HROW
33.3%
26.7%
UTL
Higher net margin
UTL
UTL
4.3% more per $
UTL
11.8%
7.4%
HROW
More free cash flow
HROW
HROW
$44.4M more FCF
HROW
$8.1M
$-36.3M
UTL
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
-4.9%
UTL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HROW
HROW
UTL
UTL
Revenue
$89.1M
$161.5M
Net Profit
$6.6M
$19.0M
Gross Margin
79.3%
Operating Margin
17.5%
21.5%
Net Margin
7.4%
11.8%
Revenue YoY
33.3%
26.7%
Net Profit YoY
-2.2%
21.8%
EPS (diluted)
$0.20
$1.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
UTL
UTL
Q4 25
$89.1M
$161.5M
Q3 25
$71.6M
$101.1M
Q2 25
$63.7M
$102.6M
Q1 25
$47.8M
$170.8M
Q4 24
$66.8M
$127.5M
Q3 24
$49.3M
$92.9M
Q2 24
$48.9M
$95.7M
Q1 24
$34.6M
$178.7M
Net Profit
HROW
HROW
UTL
UTL
Q4 25
$6.6M
$19.0M
Q3 25
$1.0M
$-300.0K
Q2 25
$5.0M
$4.0M
Q1 25
$-17.8M
$27.5M
Q4 24
$6.8M
$15.6M
Q3 24
$-4.2M
$0
Q2 24
$-6.5M
$4.3M
Q1 24
$-13.6M
$27.2M
Gross Margin
HROW
HROW
UTL
UTL
Q4 25
79.3%
Q3 25
75.3%
Q2 25
74.5%
Q1 25
67.5%
Q4 24
78.8%
Q3 24
75.6%
Q2 24
74.4%
Q1 24
69.5%
Operating Margin
HROW
HROW
UTL
UTL
Q4 25
17.5%
21.5%
Q3 25
20.6%
6.9%
Q2 25
17.9%
13.0%
Q1 25
-23.5%
27.0%
Q4 24
19.3%
22.1%
Q3 24
2.7%
6.2%
Q2 24
3.1%
13.0%
Q1 24
-20.0%
24.7%
Net Margin
HROW
HROW
UTL
UTL
Q4 25
7.4%
11.8%
Q3 25
1.4%
-0.3%
Q2 25
7.8%
3.9%
Q1 25
-37.2%
16.1%
Q4 24
10.1%
12.2%
Q3 24
-8.6%
Q2 24
-13.2%
4.5%
Q1 24
-39.2%
15.2%
EPS (diluted)
HROW
HROW
UTL
UTL
Q4 25
$0.20
$1.05
Q3 25
$0.03
$-0.02
Q2 25
$0.13
$0.25
Q1 25
$-0.50
$1.69
Q4 24
$0.19
$0.97
Q3 24
$-0.12
$0.00
Q2 24
$-0.18
$0.27
Q1 24
$-0.38
$1.69

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
UTL
UTL
Cash + ST InvestmentsLiquidity on hand
$72.9M
$15.6M
Total DebtLower is stronger
$250.0M
$670.5M
Stockholders' EquityBook value
$52.4M
$609.6M
Total Assets
$399.5M
$2.1B
Debt / EquityLower = less leverage
4.77×
1.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
UTL
UTL
Q4 25
$72.9M
$15.6M
Q3 25
$74.3M
$14.6M
Q2 25
$53.0M
$8.5M
Q1 25
$66.7M
$10.2M
Q4 24
$47.2M
$6.3M
Q3 24
$72.6M
$6.3M
Q2 24
$71.0M
$2.8M
Q1 24
$76.0M
$6.3M
Total Debt
HROW
HROW
UTL
UTL
Q4 25
$250.0M
$670.5M
Q3 25
$347.2M
$670.5M
Q2 25
$250.6M
$640.7M
Q1 25
$256.9M
$642.1M
Q4 24
$262.7M
$643.3M
Q3 24
$230.7M
$643.3M
Q2 24
$236.3M
$511.3M
Q1 24
$243.4M
$512.8M
Stockholders' Equity
HROW
HROW
UTL
UTL
Q4 25
$52.4M
$609.6M
Q3 25
$47.0M
$597.2M
Q2 25
$49.7M
$532.8M
Q1 25
$56.5M
$534.1M
Q4 24
$69.7M
$512.5M
Q3 24
$58.0M
$502.4M
Q2 24
$58.5M
$508.8M
Q1 24
$60.6M
$510.8M
Total Assets
HROW
HROW
UTL
UTL
Q4 25
$399.5M
$2.1B
Q3 25
$363.1M
$1.9B
Q2 25
$345.0M
$1.9B
Q1 25
$364.2M
$1.9B
Q4 24
$389.0M
$1.8B
Q3 24
$351.5M
$1.7B
Q2 24
$306.6M
$1.7B
Q1 24
$295.5M
$1.7B
Debt / Equity
HROW
HROW
UTL
UTL
Q4 25
4.77×
1.10×
Q3 25
7.39×
1.12×
Q2 25
5.05×
1.20×
Q1 25
4.55×
1.20×
Q4 24
3.77×
1.26×
Q3 24
3.98×
1.28×
Q2 24
4.04×
1.00×
Q1 24
4.02×
1.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
UTL
UTL
Operating Cash FlowLast quarter
$8.4M
$21.4M
Free Cash FlowOCF − Capex
$8.1M
$-36.3M
FCF MarginFCF / Revenue
9.1%
-22.5%
Capex IntensityCapex / Revenue
0.4%
35.7%
Cash ConversionOCF / Net Profit
1.27×
1.13×
TTM Free Cash FlowTrailing 4 quarters
$43.0M
$-53.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
UTL
UTL
Q4 25
$8.4M
$21.4M
Q3 25
$16.6M
$15.6M
Q2 25
$-803.0K
$42.2M
Q1 25
$19.7M
$52.1M
Q4 24
$-17.8M
$23.3M
Q3 24
$3.0M
$26.1M
Q2 24
$-2.7M
$49.9M
Q1 24
$-4.6M
$26.6M
Free Cash Flow
HROW
HROW
UTL
UTL
Q4 25
$8.1M
$-36.3M
Q3 25
$16.4M
$-39.0M
Q2 25
$-969.0K
$2.0M
Q1 25
$19.5M
$19.5M
Q4 24
$-18.3M
$-32.3M
Q3 24
$2.3M
$-31.3M
Q2 24
$-3.1M
$13.2M
Q1 24
$-4.7M
$6.4M
FCF Margin
HROW
HROW
UTL
UTL
Q4 25
9.1%
-22.5%
Q3 25
22.9%
-38.6%
Q2 25
-1.5%
1.9%
Q1 25
40.8%
11.4%
Q4 24
-27.4%
-25.3%
Q3 24
4.8%
-33.7%
Q2 24
-6.3%
13.8%
Q1 24
-13.6%
3.6%
Capex Intensity
HROW
HROW
UTL
UTL
Q4 25
0.4%
35.7%
Q3 25
0.3%
54.0%
Q2 25
0.3%
39.2%
Q1 25
0.4%
19.1%
Q4 24
0.8%
43.6%
Q3 24
1.2%
61.8%
Q2 24
0.7%
38.3%
Q1 24
0.3%
11.3%
Cash Conversion
HROW
HROW
UTL
UTL
Q4 25
1.27×
1.13×
Q3 25
16.26×
Q2 25
-0.16×
10.55×
Q1 25
1.89×
Q4 24
-2.62×
1.49×
Q3 24
Q2 24
11.60×
Q1 24
0.98×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons